Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Update: TriSalus Life Sciences Shares Rise After Receiving FDA Clearance for TriNav Advance

Update: TriSalus Life Sciences Shares Rise After Receiving FDA Clearance for TriNav Advance

MT newswireMT newswire2026/09/23 18:21
02:21 PM EDT, 09/23/2026 (MT Newswires) -- (Updates with the latest stock move in the headline and the first paragraph.) TriSalus Life Sciences (TLSI) shares were up 5.9% in Wednesday trading after the company said late Tuesday it received US Food and Drug Administration clearance for TriNav Advance, the newest addition to its Pressure-Enabled Drug Delivery portfolio. TriNav Advance provides access to small, distal vessels via a compatible delivery microcatheter, the company said. The company said it plans to initiate a limited market release of the TriNav Advance device over the coming weeks. Price: 5.22, Change: +0.29, Percent Change: +5.88
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion

Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.

智通财经•2026/11/10 04:31

Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output

Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.

智通财经•2026/11/10 04:12